Targeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyond.
Ontology highlight
ABSTRACT: Marginal zone lymphoma (MZL) represents a group of three distinct though overlapping lymphoid malignancies that includes extranodal, nodal and splenic marginal lymphoma. MZL patients usually present an indolent clinical course, although the disease remains largely incurable, save early stage disease that might be irradiated. Therapeutic advances have been limited due to the small patient population, and have largely been adapted from other indolent lymphomas. Here, we discuss the numerous targets and pathways which may offer the prospect of directly inhibiting the mechanisms identified promoting and sustaining marginal zone lymphomagenesis. In particular, we focus on the agents that may have at least a theoretical application in the disease. Various dysregulated pathways converge to produc
SUBMITTER: Lue JK
PROVIDER: S-EPMC7611845 | biostudies-literature | 2020 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA